Literature DB >> 33870199

Ranitidine for pruritus management in an infant.

B Raithatha1, C Kotzur2, A Al Mahdy2, J Schults2, J Richards2, D Rosen2.   

Abstract

Entities:  

Keywords:  H2‐blockers; WHO analgesic ladder; pain terms

Year:  2021        PMID： 33870199      PMCID： PMC8044707          DOI： 10.1002/anr3.12096

Source DB:  PubMed          Journal:  Anaesth Rep        ISSN： 2637-3726


× No keyword cloud information.
  4 in total

Review 1.  Therapy of pruritus.

Authors:  Tejesh Patel; Gil Yosipovitch
Journal:  Expert Opin Pharmacother       Date:  2010-07       Impact factor: 3.889

Review 2.  Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.

Authors:  Martin Steinhoff; John Bienenstock; Martin Schmelz; Marcus Maurer; Ed Wei; Tamás Bíró
Journal:  J Invest Dermatol       Date:  2006-08       Impact factor: 8.551

3.  Ranitidine (150 mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests.

Authors:  Maciej Kupczyk; Izabela Kupryś; Małgorzata Bocheńska-Marciniak; Paweł Górski; Piotr Kuna
Journal:  Allergy Asthma Proc       Date:  2007 Nov-Dec       Impact factor: 2.587

4.  Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients.

Authors:  E Paul; R H Bödeker
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.